PG
HAE icon

PEAK6 Group’s Haemonetics HAE Stock Holding History

PEAK6 Group’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$275K Buy
+3,071
New +$259K ﹤0.01% 3094
2017
Q1 		– Sell
-2,077
Closed -$83K – 4550
2016
Q4 		$83K Sell
2,077
-4,810
-70% -$181K ﹤0.01% 3971
2016
Q3 		$249K Buy
+6,887
New +$236K ﹤0.01% 2973
2014
Q2 		– Sell
-4,167
Closed -$136K – 4795
2014
Q1 		$136K Buy
+4,167
New +$159K ﹤0.01% 3727

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PEAK6 Group's HAE Position: Q2 2018 in Review

PEAK6 Group opened a new position in Haemonetics (HAE) in Q2 2018: 3,071 shares worth $275K. The stake represents ﹤0.01% of the portfolio and ranks #3094 among its holdings. This is a return to the name: PEAK6 Group previously reported a position in HAE as recently as Q4 2016.

PEAK6 Group first reported a position in HAE in Q1 2014 and has held it in 4 quarters since. 293 funds tracked by Wall St. Rank hold HAE as of Q2 2018.

  • PEAK6 Group held 3,071 shares of Haemonetics worth $275K as of Q2 2018.
  • Haemonetics was a new PEAK6 Group position in Q2 2018.
  • Haemonetics made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #3094 holding.
  • PEAK6 Group first reported a position in Haemonetics in Q1 2014 and has held it in 4 quarters since.
  • 293 funds tracked by Wall St. Rank held Haemonetics as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.